EcoDrugPlus

Glucosylceramidase Beta 1

Ensembl ID : ENSSARG00000001053
Gene Symbol: GBA1
1 External references
252 Possible Orthologues:

Glutamate Ionotropic Receptor Ampa Type Subunit 2

Ensembl ID : ENSSARG00000001093
Gene Symbol: GRIA2
1 External references
320 Possible Orthologues:

Glutamate Ionotropic Receptor Ampa Type Subunit 3

Ensembl ID : ENSSARG00000010455
Gene Symbol: GRIA3
1 External references
318 Possible Orthologues:

Glutamate Ionotropic Receptor Ampa Type Subunit 4

Ensembl ID : ENSSARG00000005683
Gene Symbol: GRIA4
1 External references
323 Possible Orthologues:

Glutamate Ionotropic Receptor Nmda Type Subunit 2b

Ensembl ID : ENSSARG00000013070
Gene Symbol: GRIN2B
1 External references
330 Possible Orthologues:

Glutamate Ionotropic Receptor Nmda Type Subunit 3a

Ensembl ID : ENSSARG00000012050
Gene Symbol: GRIN3A
1 External references
245 Possible Orthologues:

Glutamate Ionotropic Receptor Kainate Type Subunit 1

Ensembl ID : ENSSARG00000002141
Gene Symbol: GRIK1
1 External references
302 Possible Orthologues:

Glutamate Ionotropic Receptor Kainate Type Subunit 2

Ensembl ID : ENSSARG00000001159
Gene Symbol: GRIK2
1 External references
331 Possible Orthologues:

Glutamate Metabotropic Receptor 2

Ensembl ID : ENSSARG00000011408
Gene Symbol: GRM2
1 External references
276 Possible Orthologues:

Glutamate Metabotropic Receptor 3

Ensembl ID : ENSSARG00000000608
Gene Symbol: GRM3
1 External references
215 Possible Orthologues:

Glutamate Metabotropic Receptor 5

Ensembl ID : ENSSARG00000013408
Gene Symbol: GRM5
1 External references
272 Possible Orthologues:

Glutaminase

Ensembl ID : ENSSARG00000013321
Gene Symbol: GLS
1 External references
302 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).